Eurobank: new HealthTech Cluster for health innovation

It aims to develop the innovation ecosystem in health and biotechnology. The Cluster involves startups, research institutions and organisations that foster the interconnection of research, entrepreneurship and investment capital.

Eurobank: new HealthTech Cluster for health innovation

This article is an AI translation of an original piece published in Greek. Read original

Eurobank, through its Venture Banking division and the egg Accelerator, is launching the new HealthTech Cluster, a specialized innovation consortium aimed at developing the innovation ecosystem in the life sciences sector, with a focus on innovative technologies in the fields of health, biotechnology, pharmaceuticals, and related scientific fields in Greece, as well as its international connections with the investment and business community.

According to the relevant announcement, the new Cluster brings together growing startups, research institutions, and innovation bodies, creating a comprehensive framework for collaboration on the development of technological solutions in the health sector.

Through specialized financing tools, access to investment capital, and international business development networks, the initiative aims to enhance the investment readiness and international outreach of companies in the sector.

The HealthTech Cluster was officially launched on May 27, 2026, at the egg Hub, and is also participating in Panathēnea 2026 through the Eurobank | egg booth, highlighting the Bank’s strategic approach to creating interconnected innovation ecosystems with sector-specific expertise.

The companies participating in the new Cluster are: 2bullMeDiTherapy, AidPlex, Anacalypsis Therapeutics, Anthestos Pharmaceuticals, Carepoi, CloudPharm, MEDIPASS, METABIO, MIMA Technologies, Noetiv, OLONPHOS, Pleioflow, and StArtbio. Twelve of the 13 participating companies have been supported by the egg Accelerator, confirming the accelerator’s active role in the development of Greek innovation and entrepreneurship.

Leading research and academic institutions also participate in the Cluster, such as the National Center for Research and Technological Development (CERTH) and the Fleming Research Foundation, strengthening the link between research and the market and contributing to the creation of a dynamic framework for collaboration between science, technology, and entrepreneurship.

The HealthTech Cluster represents the next step in Eurobank and egg’s strategy for developing thematic innovation clusters and is the second cluster to be launched under this initiative. It follows the launch of the Tourism and Culture Cluster, which was implemented in two phases.

In the first phase, 12 innovative companies participated, developing comprehensive technological solutions with total funding of €2.8 million, while in the second phase the cluster expanded and now comprises a total of 16 Greek companies.

The initiative is part of an overall strategy to support sectors with a strong growth potential for the Greek economy, through synergies, innovation, and access to financing.

Ms. Roula Bachtalia, Head of Venture Banking at Eurobank, stated: “The launch of the HealthTech Cluster reaffirms Eurobank’s strategic commitment to investing in the creation of robust innovation ecosystems with an international orientation and a substantial impact on growth. Through Venture Banking and egg, we are creating the conditions for innovative Greek companies to gain access to financing, expertise, and international collaboration networks, thereby enhancing their investment maturity and competitiveness on a global scale.

The health and biotechnology sector is one of the most dynamic pillars of innovation globally, and we aspire to actively contribute to establishing Greece as a benchmark in the wider region.”

Through strategic investment in collaboration between entrepreneurship, research, and technology, Eurobank continues to strengthen a modern and outward-looking model for the development of Greek innovation, reaffirming its role as a strategic partner of new entrepreneurship.

egg enter grow go is the largest innovation and entrepreneurship accelerator in Greece and one of the largest in Europe. Through a comprehensive support framework for startups and innovative businesses, it offers access to funding, business mentoring, international networks, and opportunities for collaboration with the market, actively contributing to the development of the Greek innovation ecosystem and its integration with the international market, the announcement concludes.

v
Privacy